Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis

被引:31
作者
Dong, Charlotte X. [1 ]
Brubaker, Patricia L. [1 ]
机构
[1] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada
基金
加拿大健康研究院;
关键词
GLUCAGON-LIKE PEPTIDE-1; REDUCES FOOD-INTAKE; PROTEIN-COUPLED RECEPTORS; GASTRIC BYPASS; BODY-WEIGHT; INSULIN-SECRETION; CELL-FUNCTION; GUT HORMONE; FATTY-ACIDS; IN-VIVO;
D O I
10.1038/nrgastro.2012.185
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Dysregulation of nutrient homeostasis is implicated in the current epidemics of obesity and type 2 diabetes mellitus. The maintenance of homeostasis in the setting of repeated cycles of feeding and fasting occurs through complex interactions between metabolic, hormonal and neural factors. Although pancreatic islets, the liver, muscle, adipocytes and the central nervous system are all key players in this network, the gastrointestinal tract is the first tissue exposed to ingested nutrients and thus has an important role. This Review focuses on several of the endocrine hormones released by the gastrointestinal tract prior to or during nutrient ingestion that have key roles in maintaining energy balance. These hormones include the gastric orexigenic hormone, ghrelin, and the distal L cell anorexigenic and metabolic hormones, glucagon-like peptide (GLP)-1, GLP-2, oxyntomodulin and peptide YY. Each of these hormones exerts a distinct set of biological actions to maintain nutrient homeostasis, the properties of which are currently, or might soon be, exploited in the clinic for the treatment of obesity and type 2 diabetes mellitus. Dong, C. X. & Brubaker, P. L. Nat. Rev. Gastroenterol. Hepatol. 9, 705-715 (2012); published online 2 October 2012; doi:10.1038/nrgastro.2012.185
引用
收藏
页码:705 / 715
页数:11
相关论文
共 190 条
  • [1] Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus
    Aaboe, K.
    Knop, F. K.
    Vilsboll, T.
    Deacon, C. F.
    Holst, J. J.
    Madsbad, S.
    Krarup, T.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (04) : 323 - 333
  • [2] Blockade of the neuropeptide YY2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake
    Abbott, CR
    Small, CJ
    Kennedy, AR
    Neary, NM
    Sajedi, A
    Ghatei, MA
    Bloom, SR
    [J]. BRAIN RESEARCH, 2005, 1043 (1-2) : 139 - 144
  • [3] A PYY Q62P variant linked to human obesity
    Ahituv, N
    Kavaslar, N
    Schackwitz, W
    Ustaszewska, A
    Collier, JM
    Hébert, S
    Doelle, H
    Dent, R
    Pennacchio, LA
    McPherson, R
    [J]. HUMAN MOLECULAR GENETICS, 2006, 15 (03) : 387 - 391
  • [4] Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice
    Ahrén, B
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2004, 286 (02) : R269 - R272
  • [5] Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
    Ahren, Bo
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) : 369 - 385
  • [6] The physiological significance and potential clinical applications of ghrelin
    Akamizu, Takashi
    Kangawa, Kenji
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (03) : 197 - 202
  • [7] Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis
    Ali, Safina
    Lamont, Benjamin J.
    Charron, Maureen J.
    Drucker, Daniel J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (05) : 1917 - 1929
  • [8] Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat
    Anini, Y
    Fu-Cheng, XM
    Cuber, JC
    Kervran, A
    Chariot, J
    Rozé, C
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1999, 438 (03): : 299 - 306
  • [9] Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats
    Anini, Y
    Jarrousse, C
    Chariot, J
    Nagain, C
    Yanaihara, N
    Sasaki, K
    Bernad, N
    Nguyen, DL
    Bataille, D
    Rozé, C
    [J]. PANCREAS, 2000, 20 (04) : 348 - 360
  • [10] Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells
    Anini, Y
    Brubaker, PL
    [J]. ENDOCRINOLOGY, 2003, 144 (07) : 3244 - 3250